|
End-of-day quote
Ghana S.E.
|
||
| - GHS | - |
|
| Market Cap | 5.2M 60.65M 4.59M 4.34M 3.93M 7.38M 499M 7.45M 52.05M 20.06M 255M 19.51M 19.09M 819M | P/E 2017 |
11.7x | P/E 2018 | 6.9x |
|---|---|---|---|---|---|
| Enterprise Value | 10.45M 122M 9.22M 8.72M 7.91M 14.83M 1B 14.98M 105M 40.33M 512M 39.22M 38.37M 1.65B | EV / Sales 2017 |
1.34x | EV / Sales 2018 | 1.05x |
| Free-Float |
26.89% | Yield 2017 * |
-
| Yield 2018 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | 0.00% | - | - | 915K | ||
| +0.13% | +1.42% | +63.35% | +120.95% | 1,056B | ||
| -1.77% | -0.72% | +47.15% | +71.60% | 655B | ||
| -0.93% | -0.54% | +18.20% | +76.96% | 471B | ||
| -1.72% | -4.06% | +36.39% | +39.47% | 342B | ||
| -0.40% | +3.83% | +22.08% | +28.82% | 277B | ||
| -0.51% | -1.93% | +12.09% | +11.94% | 257B | ||
| +0.59% | +2.70% | +53.79% | +56.77% | 226B | ||
| -0.52% | -0.99% | +34.23% | +101.71% | 189B | ||
| -0.24% | -2.76% | -28.41% | -60.92% | 170B | ||
| Average | -0.61% | +0.97% | +28.76% | +49.70% | 364.29B | |
| Weighted average by Cap. | -0.64% | +1.04% | +38.94% | +70.58% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 8.89M 104M 7.85M 7.43M 6.73M 12.62M 853M 12.75M 89.08M 34.33M 436M 33.39M 32.67M 1.4B | 9.91M 116M 8.75M 8.27M 7.5M 14.07M 951M 14.21M 99.26M 38.26M 486M 37.21M 36.4M 1.56B |
| Net income | 665K 7.76M 587K 555K 504K 944K 63.81M 953K 6.66M 2.57M 32.59M 2.5M 2.44M 105M | 762K 8.89M 672K 636K 577K 1.08M 73.07M 1.09M 7.63M 2.94M 37.31M 2.86M 2.8M 120M |
| Net Debt | 4.15M 48.41M 3.66M 3.46M 3.14M 5.89M 398M 5.95M 41.54M 16.01M 203M 15.57M 15.23M 654M | 5.25M 61.28M 4.63M 4.38M 3.98M 7.45M 504M 7.53M 52.59M 20.27M 257M 19.71M 19.28M 828M |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- SPL Stock
Select your edition
All financial news and data tailored to specific country editions
















